ArticleThe Journal of biological chemistry2014

Mitogen-activated protein kinase (MAPK) hyperactivation and enhanced NRAS expression drive acquired vemurafenib resistance in V600E BRAF melanoma cells.

Michael Lidsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.